SNA International Awarded $135.6M DoW Contract
SNA International Awarded $135.6M DoW Contract
PR Newswire
ALEXANDRIA, Va., July 21, 2026
ALEXANDRIA, Va., July 21, 2026 /PRNewswire/ -- SNA International is pleased to announce it was awarded the Armed Forces Medical Examiner System (AFMES) Scientific, Technical, Administrative, and Logistical Support Services (STALSS) contract, a single-award indefinite-delivery/indefinite-quantity (IDIQ) contract with a ceiling of $135.6M. The award sustains SNA's role in providing scientific, technical, administrative, and logistical support that underpins AFMES forensic operations, including medico-legal death investigation, forensic pathology, DNA identification, and forensic toxicology, in support of the Department of War.
"AFMES carries out work that families and the nation depend on, and the standard for that mission is absolute," said Ryan Hayes, President of SNA International. "Our focus is simple: provide skilled, cleared personnel who integrate without disruption, sustain laboratory and operational throughput, and uphold the rigor these cases demand. We are honored to have been chosen to support AFMES across its full range of forensic responsibilities."
Headquartered in Alexandria, VA, SNA International has been a mission-driven prime contractor supporting biometric, forensic, and identity intelligence missions since 2002. With more than two decades of experience delivering science-driven and operationally rigorous solutions, SNA has established a record of exceptional performance across its state, local, and federal customers.
SOURCE SNA International
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
3 Stocks to Invest In With More Room to Run
United States